STU:BIG (Germany)
Â
Akt. nach Kapitalherabsetzung
€
2.75
(0%)
Jul 30
Business Description
Bio-Gate AG
ISIN : DE000BGAG0J3
Share Class Description:
STU:BIG: Akt. nach KapitalherabsetzungTotal Employee Number:
51Description
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.3 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.9 | |||||
Beneish M-Score | -1.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 22.3 | |||||
3-Year EPS without NRI Growth Rate | 19.5 | |||||
3-Year FCF Growth Rate | 24 | |||||
3-Year Book Growth Rate | -32.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.85 | |||||
9-Day RSI | 40.23 | |||||
14-Day RSI | 43.03 | |||||
3-1 Month Momentum % | -18.18 | |||||
6-1 Month Momentum % | -19.31 | |||||
12-1 Month Momentum % | -40.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.46 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 0.62 | |||||
Days Inventory | 168.85 | |||||
Days Sales Outstanding | 17.5 | |||||
Days Payable | 82.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.6 | |||||
Shareholder Yield % | -15.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.21 | |||||
Operating Margin % | -15.25 | |||||
Net Margin % | -15.75 | |||||
EBITDA Margin % | -12.1 | |||||
FCF Margin % | -19.11 | |||||
OCF Margin % | -13.61 | |||||
ROE % | -83.35 | |||||
ROA % | -27.33 | |||||
ROIC % | -42.21 | |||||
3-Year ROIIC % | -98.94 | |||||
ROC (Joel Greenblatt) % | -73.71 | |||||
ROCE % | -37.13 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 7 | |||||
PS Ratio | 0.72 | |||||
PB Ratio | 3.66 | |||||
Price-to-Tangible-Book | 18.33 | |||||
EV-to-EBIT | -5.32 | |||||
EV-to-Forward-EBIT | -7.78 | |||||
EV-to-EBITDA | -6.72 | |||||
EV-to-Forward-EBITDA | -15.56 | |||||
EV-to-Revenue | 0.81 | |||||
EV-to-Forward-Revenue | 0.63 | |||||
EV-to-FCF | -4.25 | |||||
Price-to-Median-PS-Value | 0.2 | |||||
Earnings Yield (Greenblatt) % | -18.8 | |||||
FCF Yield % | -21.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Gate AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 7.399 | ||
| EPS (TTM) (€) | -0.613 | ||
| Beta | 0.7368 | ||
| 3-Year Sharpe Ratio | -0.62 | ||
| 3-Year Sortino Ratio | -0.79 | ||
| Volatility % | 42.38 | ||
| 14-Day RSI | 43.03 | ||
| 14-Day ATR (€) | 0.260398 | ||
| 20-Day SMA (€) | 2.92 | ||
| 12-1 Month Momentum % | -40.61 | ||
| 52-Week Range (€) | 2.4 - 4.975 | ||
| Shares Outstanding (Mil) | 2.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Gate AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Gate AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.2:1 Stock Split | 2026-07-28 | 2.75 (+10.00%) |
Show
Entries
Bio-Gate AG Frequently Asked Questions
What is Bio-Gate AG(STU:BIG)'s stock price today?
The current price of STU:BIG is €2.75. The 52 week high of STU:BIG is €4.97 and 52 week low is €2.40.
When is next earnings date of Bio-Gate AG(STU:BIG)?
The next earnings date of Bio-Gate AG(STU:BIG) is .
Does Bio-Gate AG(STU:BIG) pay dividends? If so, how much?
Bio-Gate AG(STU:BIG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bio-Gate AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers